Cases & Deals

CARMAT completes €40.5 million share capital increase

Client(s) CARMAT SA

Jones Day represented CARMAT SA, the designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative to people suffering from end-stage biventricular heart failure, with its €40.5 million share capital increase, of which €36.5 million is aimed at specialized and strategic investors and €4.1 million for individuals (via the PrimaryBid platform).